Enhanced Recovery Pathway Boosting Postsurgical Outcomes in Peritoneal Metastasis Patients
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to improve clinical outcomes and prognosis in patients with peritoneal metastasis. However, it is associated with a significant complication rate and a long postsurgical recovery in the hospital.
Read More